 | • レポートコード：MRC2-11QY04256 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医薬品のグローバル市場について調査・分析したレポートです。種類別（がん治療薬、鎮痛薬、降圧薬、糖尿病治療薬、その他）市場規模、用途別（オンライン、オフライン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医薬品の競争状況、市場シェア ・世界の医薬品市場：種類別市場規模 2015年-2020年（がん治療薬、鎮痛薬、降圧薬、糖尿病治療薬、その他） ・世界の医薬品市場：種類別市場規模予測 2021年-2026年（がん治療薬、鎮痛薬、降圧薬、糖尿病治療薬、その他） ・世界の医薬品市場：用途別市場規模 2015年-2020年（オンライン、オフライン） ・世界の医薬品市場：用途別市場規模予測 2021年-2026年（オンライン、オフライン） ・北米の医薬品市場分析：米国、カナダ ・ヨーロッパの医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Merck、AbbVie、Novartis、Roche、GlaxoSmithKline、AstraZeneca、French Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is inarguable.
North America is responsible for the largest portion of these revenues, due to the leading role of the U.S. pharmaceutical industry. However, as in many other industries, the Chinese pharmaceutical sector has shown the highest growth rates over previous years.
Market Analysis and Insights: Global Pharmaceuticals Market
The global Pharmaceuticals market size is projected to reach US$ 993180 million by 2026, from US$ 960000 million in 2020, at a CAGR of 3.2%% during 2021-2026.
Global Pharmaceuticals Scope and Market Size
Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Merck
AbbVie
Novartis
Roche
GlaxoSmithKline
AstraZeneca
French Sanofi
Market segment by Type, the product can be split into
Cancer Drugs
Pain Drugs
Antihypertensives
Antidiabetics
Other
Market segment by Application, split into
Online
Offline
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceuticals Revenue
1.4 Market by Type
1.4.1 Global Pharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cancer Drugs
1.4.3 Pain Drugs
1.4.4 Antihypertensives
1.4.5 Antidiabetics
1.4.6 Other
1.5 Market by Application
1.5.1 Global Pharmaceuticals Market Share by Application: 2020 VS 2026
1.5.2 Online
1.5.3 Offline
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceuticals Market Perspective (2015-2026)
2.2 Global Pharmaceuticals Growth Trends by Regions
2.2.1 Pharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceuticals Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceuticals Players by Market Size
3.1.1 Global Top Pharmaceuticals Players by Revenue (2015-2020)
3.1.2 Global Pharmaceuticals Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceuticals Market Concentration Ratio
3.2.1 Global Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceuticals Revenue in 2019
3.3 Pharmaceuticals Key Players Head office and Area Served
3.4 Key Players Pharmaceuticals Product Solution and Service
3.5 Date of Enter into Pharmaceuticals Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pharmaceuticals Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceuticals Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pharmaceuticals Market Size by Application (2015-2020)
5.2 Global Pharmaceuticals Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmaceuticals Market Size (2015-2020)
6.2 Pharmaceuticals Key Players in North America (2019-2020)
6.3 North America Pharmaceuticals Market Size by Type (2015-2020)
6.4 North America Pharmaceuticals Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pharmaceuticals Market Size (2015-2020)
7.2 Pharmaceuticals Key Players in Europe (2019-2020)
7.3 Europe Pharmaceuticals Market Size by Type (2015-2020)
7.4 Europe Pharmaceuticals Market Size by Application (2015-2020)
8 China
8.1 China Pharmaceuticals Market Size (2015-2020)
8.2 Pharmaceuticals Key Players in China (2019-2020)
8.3 China Pharmaceuticals Market Size by Type (2015-2020)
8.4 China Pharmaceuticals Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pharmaceuticals Market Size (2015-2020)
9.2 Pharmaceuticals Key Players in Japan (2019-2020)
9.3 Japan Pharmaceuticals Market Size by Type (2015-2020)
9.4 Japan Pharmaceuticals Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pharmaceuticals Market Size (2015-2020)
10.2 Pharmaceuticals Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceuticals Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceuticals Market Size by Application (2015-2020)
11 India
11.1 India Pharmaceuticals Market Size (2015-2020)
11.2 Pharmaceuticals Key Players in India (2019-2020)
11.3 India Pharmaceuticals Market Size by Type (2015-2020)
11.4 India Pharmaceuticals Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pharmaceuticals Market Size (2015-2020)
12.2 Pharmaceuticals Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceuticals Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceuticals Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Pharmaceuticals Introduction
13.1.4 Johnson & Johnson Revenue in Pharmaceuticals Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Pharmaceuticals Introduction
13.2.4 Merck Revenue in Pharmaceuticals Business (2015-2020)
13.2.5 Merck Recent Development
13.3 AbbVie
13.3.1 AbbVie Company Details
13.3.2 AbbVie Business Overview
13.3.3 AbbVie Pharmaceuticals Introduction
13.3.4 AbbVie Revenue in Pharmaceuticals Business (2015-2020)
13.3.5 AbbVie Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Pharmaceuticals Introduction
13.4.4 Novartis Revenue in Pharmaceuticals Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Pharmaceuticals Introduction
13.5.4 Roche Revenue in Pharmaceuticals Business (2015-2020)
13.5.5 Roche Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Pharmaceuticals Introduction
13.6.4 GlaxoSmithKline Revenue in Pharmaceuticals Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Pharmaceuticals Introduction
13.7.4 AstraZeneca Revenue in Pharmaceuticals Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 French Sanofi
13.8.1 French Sanofi Company Details
13.8.2 French Sanofi Business Overview
13.8.3 French Sanofi Pharmaceuticals Introduction
13.8.4 French Sanofi Revenue in Pharmaceuticals Business (2015-2020)
13.8.5 French Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pharmaceuticals Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceuticals Revenue
Table 3. Ranking of Global Top Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cancer Drugs
Table 6. Key Players of Pain Drugs
Table 7. Key Players of Antihypertensives
Table 8. Key Players of Antidiabetics
Table 9. Key Players of Other
Table 10. Global Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Pharmaceuticals Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Pharmaceuticals Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Pharmaceuticals Market Share by Regions (2015-2020)
Table 14. Global Pharmaceuticals Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Pharmaceuticals Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pharmaceuticals Market Growth Strategy
Table 20. Main Points Interviewed from Key Pharmaceuticals Players
Table 21. Global Pharmaceuticals Revenue by Players (2015-2020) (Million US$)
Table 22. Global Pharmaceuticals Market Share by Players (2015-2020)
Table 23. Global Top Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals as of 2019)
Table 24. Global Pharmaceuticals by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pharmaceuticals Product Solution and Service
Table 27. Date of Enter into Pharmaceuticals Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 30. Global Pharmaceuticals Market Size Share by Type (2015-2020)
Table 31. Global Pharmaceuticals Revenue Market Share by Type (2021-2026)
Table 32. Global Pharmaceuticals Market Size Share by Application (2015-2020)
Table 33. Global Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 34. Global Pharmaceuticals Market Size Share by Application (2021-2026)
Table 35. North America Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Pharmaceuticals Market Share (2019-2020)
Table 37. North America Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 38. North America Pharmaceuticals Market Share by Type (2015-2020)
Table 39. North America Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 40. North America Pharmaceuticals Market Share by Application (2015-2020)
Table 41. Europe Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Pharmaceuticals Market Share (2019-2020)
Table 43. Europe Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Pharmaceuticals Market Share by Type (2015-2020)
Table 45. Europe Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Pharmaceuticals Market Share by Application (2015-2020)
Table 47. China Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 48. China Key Players Pharmaceuticals Market Share (2019-2020)
Table 49. China Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 50. China Pharmaceuticals Market Share by Type (2015-2020)
Table 51. China Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 52. China Pharmaceuticals Market Share by Application (2015-2020)
Table 53. Japan Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Pharmaceuticals Market Share (2019-2020)
Table 55. Japan Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Pharmaceuticals Market Share by Type (2015-2020)
Table 57. Japan Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Pharmaceuticals Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Pharmaceuticals Market Share (2019-2020)
Table 61. Southeast Asia Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Pharmaceuticals Market Share by Type (2015-2020)
Table 63. Southeast Asia Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Pharmaceuticals Market Share by Application (2015-2020)
Table 65. India Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 66. India Key Players Pharmaceuticals Market Share (2019-2020)
Table 67. India Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 68. India Pharmaceuticals Market Share by Type (2015-2020)
Table 69. India Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 70. India Pharmaceuticals Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Pharmaceuticals Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Pharmaceuticals Market Share (2019-2020)
Table 73. Central & South America Pharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Pharmaceuticals Market Share by Type (2015-2020)
Table 75. Central & South America Pharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Pharmaceuticals Market Share by Application (2015-2020)
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 81. Johnson & Johnson Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Product
Table 85. Merck Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 86. Merck Recent Development
Table 87. AbbVie Company Details
Table 88. AbbVie Business Overview
Table 89. AbbVie Product
Table 90. AbbVie Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 91. AbbVie Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Product
Table 95. Novartis Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 96. Novartis Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Product
Table 100. Roche Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 101. Roche Recent Development
Table 102. GlaxoSmithKline Company Details
Table 103. GlaxoSmithKline Business Overview
Table 104. GlaxoSmithKline Product
Table 105. GlaxoSmithKline Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 106. GlaxoSmithKline Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Product
Table 110. AstraZeneca Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 111. AstraZeneca Recent Development
Table 112. French Sanofi Business Overview
Table 113. French Sanofi Product
Table 114. French Sanofi Company Details
Table 115. French Sanofi Revenue in Pharmaceuticals Business (2015-2020) (Million US$)
Table 116. French Sanofi Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceuticals Market Share by Type: 2020 VS 2026
Figure 2. Cancer Drugs Features
Figure 3. Pain Drugs Features
Figure 4. Antihypertensives Features
Figure 5. Antidiabetics Features
Figure 6. Other Features
Figure 7. Global Pharmaceuticals Market Share by Application: 2020 VS 2026
Figure 8. Online Case Studies
Figure 9. Offline Case Studies
Figure 10. Pharmaceuticals Report Years Considered
Figure 11. Global Pharmaceuticals Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pharmaceuticals Market Share by Regions: 2020 VS 2026
Figure 13. Global Pharmaceuticals Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pharmaceuticals Market Share by Players in 2019
Figure 16. Global Top Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceuticals Revenue in 2019
Figure 18. North America Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
変形性関節症鎮痛薬の世界市場（～2026年） Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis. Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Re…- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 抗てんかん薬の世界市場（～2026年） Market Analysis and Insights: Global Antiepileptic Drugs Market The global Antiepileptic Drugs market size is projected to reach US$ 4076.9 million by 2026, from US$ 3984.1 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Antiepileptic Drugs Scope and Market Size Antiepileptic Drugs mark…
- 糖尿病網膜症（DR）治療薬の世界市場（～2026年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…